Insulin Therapy. What’s New?
The article deals with the need for insulin therapy in patients with diabetes mellitus (DM) type 2. In recent years, the indications for insulin therapy in patients with DM type 2 have increased significantly. According to the UK prospective DM (UKPDS), annually 5–10 % of patients with newly diagnos...
Main Authors: | B.N. Mankovsky, N.N. Zherdeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2013-04-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/84317 |
Similar Items
-
Insuman® Basal, Insuman® Comb, Insuman® Rapid in SoloStar® Disposable Pens — the Only Human Insulins in SoloStar® Disposable Pens in Ukraine
by: O.V. Korpacheva-Zinych, et al.
Published: (2013-03-01) -
Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
by: Eun Yeong Choe, et al.
Published: (2012-06-01) -
Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus
by: Puhong Zhang, et al.
Published: (2020-04-01) -
Intensive Insulin Titration with Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study
by: Ercan Tuncel, et al.
Published: (2015-09-01) -
Using ultra-rapid insulin analogs in children and adolescents with type 1 diabetes mellitus
by: О.V. Bolshova, et al.
Published: (2017-11-01)